Lexicon Pharmaceuticals LXRX Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's common stock, par value (in dollars per share)?
- Lexicon Pharmaceuticals (LXRX) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has Lexicon Pharmaceuticals's common stock, par value (in dollars per share) changed year-over-year?
- Lexicon Pharmaceuticals's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Lexicon Pharmaceuticals's common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.